TradeShare
Options playsTheses
Sign in
Back to Options plays
Partially ExitedPATH6 contractsEntry: $226.00
Created: Wednesday, February 18, 2026
Executed: Tuesday, February 17, 2026 at 09:41 AM
Option Details: PATH $11 Call exp. Aug 21, 2026

Portfolio position

  • -20.87%TFSA
Exited: Monday, March 16, 2026 at 11:16 AM
Partial Exit SummaryProfitable
Sold: 4 contracts at $260.00
Entry Price: $226.00 per contract
Realized P/L: $136.00

PATH $11 Call expiring August 21st 2026

Structured Trade Summary

(UiPath, Inc. — $11 Call, Aug. 21st 2026, ~$2.62 premium)


1️⃣ Valuation Assessment

A multi-stage DCF was performed using three scenarios.

Current stock price (spot): ~$11.30 (at time of entry)

ScenarioStage 1 (Y1–3)Stage 2 (Y4–7)TerminalDiscountEquity ValueFair Value / ShareUpside vs $11.30
Conservative10%8%2.0%10%~$7.3B
~$13.05
~+15%
Base18%15%2.5%9%~$9.6B~$17.15~+52%
Bull20%15%2.5%8.5%~$10.6B~$18.90~+67%

Summary:

  • Conservative now clears ≥10% undervaluation rule
  • Base case shows strong margin of safety
  • Bull case justifies convex upside exposure assuming successful execution and margin expansion.

This is not a deep structural mis-pricing, but it aligns reasonably with intrinsic value under realistic execution assumptions.

Upside is primarily dependent on operational delivery rather than simple multiple expansion.


2️⃣ Catalyst Thesis

The trade is based on:

  • Continued profitability following recent earnings.
  • Expansion in free cash flow margin (current ≈21.4%, expected ≈26.4%).
  • Net income margin expansion (current ≈14.8%, expected ≈17%).
  • Reinforcement of management guidance.
  • Potential macro tailwind from a less risk-off environment if interest rates decline.

There are at least two earnings cycles before expiration, allowing time for the thesis to play out.

This is an execution confirmation thesis rather than a narrative expansion thesis.


3️⃣ Volatility Context

  • IV30 percentile is at elevated levels, as seen from https://marketchameleon.com/volReports/VolatilityRankings
  • Target expiration IV (~82%) is high.

The option is not cheap. Volatility is already pricing significant uncertainty.

Disciplined management is required because implied volatility may compress after earnings.


4️⃣ Strike Structure

  • Strike: $11
  • Delta: ~0.65
  • Premium: ~$2.65
  • Breakeven at expiration: ~$13.45 (~20–25% above current price)

The strike selection is defensive-to-balanced, appropriate in a high-IV regime.

Although breakeven at expiration requires a ~20–25% move, the position does not need to be held to expiration. Gains can be realized prior to breakeven as intrinsic value builds and delta increases.


5️⃣ Portfolio Role

When paired with higher-strike $20 calls:

  • The $11 call increases probability of capturing moderate upside.
  • It reduces reliance on explosive price movement.
  • It smooths overall exposure.
  • It acts as structural reinforcement rather than pure convex speculation.

This improves probability-weighted portfolio outcomes.


6️⃣ Risk Management

  • Position size: 2 contracts
  • Entry premium: ~$2.62
  • Stop loss: 30% ↓
  • Take profit: 30% ↑

If the option declines approximately 30% from entry, exit to preserve capital.

Take profit if a gain of at least 30% is realizable.

This defines both downside and upside parameters clearly and prevents emotional decision-making.


7️⃣ Exit Framework

  • If the stock moves 8–10%, trim the position.
  • Harvest gains while implied volatility remains elevated.
  • Reassess after earnings.
  • Exit immediately if margin expansion thesis fails.
  • Adhere strictly to predefined stop loss and profit targets.

Discipline is required due to elevated volatility at entry.


Overall Assessment

This is not a low-volatility mis-pricing opportunity.

It is a structured, execution-based trade in an elevated volatility environment.

As a standalone trade, conviction should be moderate.

As a portfolio adjustment alongside higher-strike exposure, the structure is coherent and risk-balanced.

Success depends on:

  • Measurable margin expansion,
  • Earnings confirmation,
  • Analyst revisions,
  • Active position management,
  • Strict adherence to predefined risk controls.